TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,082 | -1.5% | 3,690 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $57,968 | -5.6% | 3,690 | -1.1% | 0.00% | 0.0% |
| Q1 2023 | $61,430 | +5.6% | 3,730 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $58,187 | +21.2% | 3,730 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $48,000 | -12.7% | 3,730 | -5.2% | 0.00% | 0.0% |
| Q2 2022 | $55,000 | 0.0% | 3,936 | +2.1% | 0.00% | 0.0% |
| Q1 2022 | $55,000 | +3.8% | 3,856 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $53,000 | +39.5% | 3,856 | +68.2% | 0.00% | 0.0% |
| Q3 2021 | $38,000 | +375.0% | 2,292 | +380.5% | 0.00% | – |
| Q2 2021 | $8,000 | -11.1% | 477 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | 0.0% | 477 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | 0.0% | 477 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $9,000 | 0.0% | 477 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $9,000 | +28.6% | 477 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | -22.2% | 477 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $9,000 | +12.5% | 477 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $8,000 | 0.0% | 477 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $8,000 | -20.0% | 477 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $10,000 | – | 477 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |